We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




RNAi Library to Be a Public Resource

By Biotechdaily staff writers
Posted on 29 Nov 2004
A three-year project to establish an RNAi (RNA interference) library that targets genes linked to environmentally related diseases has recently been funded with a grant of U.S.$3 million.

RNAi is also known as antisense RNA. More...
The antisense approach to gene silencing involves injecting an organism with an RNA sequence complementary to messenger RNA (mRNA) transcribed from a target gene. The antisense RNA hybridizes with the sense mRNA and the double-stranded (DS) molecule blocks translation and production of an encoded protein. The presence of the dsRNA duplex led to what is now recognized as an RNA interference effect.

The work to develop the library's collection will be carried out by Icoria (Research Triangle Park, NC, USA), a biotechnology company that applies its proprietary systems biology platform to the discovery of safer, more effective drugs and agrichemicals. Once established, the library will be a resource available to the scientific community administered by the [U.S.] National Institute of Environmental Health Sciences (NIEHS) National Center for Toxicogenomics (Research Triangle Park, NC, USA).

"It is a rapid and powerful new tool to augment more traditional and time-consuming methods to accomplish our goal of verifying disease pathways,” said Dr. Kenneth Olden, director of the NIEHS. "We are very pleased to carry out this important work that will benefit the entire scientific community by making the information available to the public.”




Related Links:
Icoria
[U.S.] NIEHS Nat'l Center for Toxicogenomics

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Repetitive Pipette
VWR® Stepper Pro
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.